Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Drug-Related Side Effects and Adverse Reactions × Imatinib Mesylate × 90 days × Clear all

Sponsor

Conditions

Gastrointestinal Stromal Tumors 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Neoplasms 2 Burkitt Lymphoma 2 Uveal Melanoma 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Philadelphia Chromosome 1 Neoplasm, Residual 1 Myeloproliferative Disorders 1 Melanoma 1 Lymphangioleiomyomatosis 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Biphenotypic, Acute 1 Digestive System Neoplasms 1 Desmoid Tumors 1 Dermatofibrosarcoma 1 Congenital Bone Marrow Failure Syndromes 1 Chordoma 1 Carcinoma, Adenoid Cystic 1 Blast Crisis 1

Interventions

Methylprednisolone 2 pegaspargase 1 Vincristine 1 Radiotherapy 1 Prednisone 1 Prednisolone 1 Methylprednisolone Hemisuccinate 1 Methotrexate 1 Mercaptopurine 1 Leucovorin 1 Infliximab 1 Hydrocortisone 1 Fecal Microbiota Transplantation 1 Etoposide 1 Drug Therapy 1 Doxorubicin 1 Dexrazoxane 1 Dexamethasone 1 Cytarabine 1 Cyclophosphamide 1 Asparaginase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡